Journal
AMYOTROPHIC LATERAL SCLEROSIS
Volume 10, Issue 4, Pages 237-243Publisher
INFORMA HEALTHCARE
DOI: 10.1080/17482960802430781
Keywords
Amyotrophic lateral sclerosis; cost of illness; quality of life; Spain
Categories
Funding
- FEDER
- Health Institute Carlos III
- Ministry of Health and Consumer Affairs
- Spanish Epidemiological Network on Rare Diseases Research (REpIER)
- Spanish Amyotrophic Lateral Sclerosis Network
Ask authors/readers for more resources
Amyotrophic lateral sclerosis (ALS) is a process that leads to the functional disability of the individual in a relatively short period of time, with a very important limitation of autonomy and affecting the quality of life. We wished to determine the economic burden (direct and indirect costs), as well as health-related quality of life (HRQoL) in patients with ALS in Spain. A cross-sectional study was carried out on 63 patients with ALS during 2004. A retrospective assessment of the use of resources was obtained through questionnaires completed by the patients and/or the patients' caregivers. The approach used was a cost-of-illness study based on a societal perspective. We assessed the HRQoL with the EQ-5D. Mean annual cost per patient with ALS was (sic)36,194. The most important categories of costs were informal care, early retirement, medications, and orthopaedic devices. The mean EQ-5D index score was 0.18 and the mean EQ-5D VAS score was 29. Considerations of the costs related to caregiving to cope with the patients' disabilities, as well as the high indirect costs resulting from early retirement in patients with ALS, should become a priority for health authorities in Spain. The patients' HRQoL was very low and substantially influenced by the degree of severity of ALS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available